Vaxart, Inc. Contract with Customer, Asset, after Allowance for Credit Loss, Current
Vaxart, Inc. (VXRT) had Contract with Customer, Asset, after Allowance for Credit Loss, Current of $0 as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2022-02-24
- 2021-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $0.00.
- 2021-09-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $0.00.
- 2021-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $0.00.
- 2021-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $232.00K.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $232.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 |
| 2019-12-31 | $181.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $204.00K 10-Q · filed 2019-11-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |